Esorcismi. Mito, hybris, riti e coscienza
Ri-Vista. Research for landscape architecture · 08.05.2026 · 23 (2) · 78-93
DOI: 10.36253/rv-17899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ri-Vista. Research for landscape architecture, online erschienen am 08.05.2026. Verfasst von Vittoria Ghio und 1 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myth, a device for symbolic mediation between humans and the environment, capable of exorcising the otherness of the landscape through ritual, is taken as a framework for discussing the ‘excessive power’ of contemporary technology. Starting from the thinking of Aby Warburg and Carlos Casta-neda, this text sets out to investigate the landscape as a cultural construct born of tension with the extreme. Myth is knowledge and orientation.According to Warburg, the coexistence of magical dimension and rational utilitarianism describes a possible balance between imagination and design. Landscape becomes a ritual and transforma-tive space, a place where symbolic action restores meaning and measure. Myth – far from being an archaic remnant – reveals itself to be a critical resource for a dialogue with the environment based on sympoietic relationships between human and non-human, other than those which, as Turri ob-serves, derive from actions aimed at modifying and humanising the landscape.
Zitieren
APA
Ghio, V., & Tosetto, F. (2026). Esorcismi. Mito, hybris, riti e coscienza. Ri-Vista. Research for landscape architecture, 23(2), 78-93. https://doi.org/10.36253/rv-17899
Vancouver
Ghio V, Tosetto F. Esorcismi. Mito, hybris, riti e coscienza. Ri-Vista. Research for landscape architecture. 2026;23(2):78-93. doi:10.36253/rv-17899
BibTeX
@article{Ghio2026,
author = {Ghio, Vittoria and Tosetto, Francesco},
title = {Esorcismi. Mito, hybris, riti e coscienza},
journal = {Ri-Vista. Research for landscape architecture},
year = {2026},
volume = {23},
number = {2},
pages = {78--93},
doi = {10.36253/rv-17899}
}
EUVIMED